Trends in net survival for prostate cancer in Japan, 2000–14 (CONCORD-3)
Japanese Journal of Clinical Oncology · 2026
DOI: 10.1093/jjco/hyaf021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2026. Verfasst von Rina Tanaka und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Hirosaki University Graduate School of Medicine, 5 Zaifu-Cho Hirosaki City, Aomori, 036-8562, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japanese Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Background
We aimed at assessing 15-year trends in 5-year net survival for men diagnosed with prostate cancer during 2000–2014 and registered by 16 Japanese regional population-based cancer registries included in the CONCORD-3 study.
Methods
We included data on adult men (15–99 years) diagnosed with prostate cancer during 2000–2014 and followed-up to 31 December 2014. We grouped patients into five age groups (15–54, 55–64, 65–74, 75–84, and 85–99 years) and four morphology groups according to the ICD-O-3 classification (epithelial, neuroendocrine, other specified morphologies, and malignant neoplasm, not otherwise specified). We grouped patients by stage at diagnosis into localized, regional, and advanced disease. We estimated 5-year net survival by age group, morphological subtype and stage using the Pohar Perme estimator, correcting for background mortality. All-ages estimates were standardized with the International Cancer Survival Standard weights.
Results
Age-standardized 5-year net survival increased over time, from 85.9% in 2000–2004 to 93.0% in 2010–2014. Survival was higher than 90% for epithelial tumors, and for localized and regional disease. Five-year net survival for patients with distant metastasis was poor at 47.3% (95% CI. 39.4–55.1%) during 2010–2014.
Conclusions
The improvement in survival for prostate cancer may be due to the high and increasing proportion of patients with localized disease and with epithelial tumors, for which 5-year survival approaches 100%. A comprehensive analysis of long-term survival over a longer period of time would be essential to investigate further the factors contributing to the increasing trend in survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Informatics, Hirosaki University Graduate School of Medicine, 5 Zaifu-Cho Hirosaki City, Aomori, 036-8562, Japan.
- Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
- Department of Epidemiology, Radiation Effects Research Foundation, 5-2 Hijiyama Park, Minami-ku, Hiroshima, Hiroshima, 732-0815, Japan.
- Department of Health Sciences, Saitama Prefectural University, 820 Sannomiya, Koshigaya, Saitama, 343-8540, Japan.
- Yamagata Prefectural Central Hospital, 1800 Oaza-Aoyanagi, Yamagata, Yamagata, 990-2214, Japan.
- Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Osaka, 541-8567, Japan.
ORCID-Profile: Rina Tanaka, Hiromi Sugiyama, Izumi Oki, Kayo Nakata, Masashi Matsuzaka, Marisa Nishio, Isao Oze, Kaname Watanabe, Laureline Gatellier, Isao Yoshida, Norihiro Teramoto, Hiroto Narimatsu, Veronica Di Carlo
Förderung
- Japanese Ministry of Health, Labour and Welfare
Zitieren
APA
Tanaka, R., Matz, M., Sugiyama, H., Oki, I., Shibata, A., Nakata, K., Kajiwara Saito, M., Matsuzaka, M., Nishio, M., Oze, I., Watanabe, K., Gatellier, L., Yoshida, I., Ito, H., Teramoto, N., Yamashita, N., Kaizaki, Y., Moki, F., Kurosawa, K., …, & Di Carlo, V. (2026). Trends in net survival for prostate cancer in Japan, 2000–14 (CONCORD-3). Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf021
Vancouver
Tanaka R, Matz M, Sugiyama H, Oki I, Shibata A, Nakata K, et al. Trends in net survival for prostate cancer in Japan, 2000–14 (CONCORD-3). Japanese Journal of Clinical Oncology. 2026. doi:10.1093/jjco/hyaf021
BibTeX
@article{Tanaka2026,
author = {Tanaka, Rina and Matz, Melissa and Sugiyama, Hiromi and Oki, Izumi and Shibata, Akiko and Nakata, Kayo and Kajiwara Saito, Mari and Matsuzaka, Masashi and Nishio, Marisa and Oze, Isao and Watanabe, Kaname and Gatellier, Laureline and Yoshida, Isao and Ito, Hidemi and Teramoto, Norihiro and Yamashita, Natsumi and Kaizaki, Yasuharu and Moki, Fumitaka and Kurosawa, Katsuki and Nemoto, Yuji and Narimatsu, Hiroto and Kanemura, Seiki and Miyashiro, Isao and Mori, Daisuke and Fujita, Shin and Matsuda, Tomohiro and Coleman, Michel P and Allemani, Claudia and Di Carlo, Veronica},
title = {Trends in net survival for prostate cancer in Japan, 2000–14 (CONCORD-3)},
journal = {Japanese Journal of Clinical Oncology},
year = {2026},
doi = {10.1093/jjco/hyaf021}
}
EUVIMED